Wednesday, 19 December 2018

Reuters Health Report: J&J says Indian drug regulators visited facilities, took talc samples

Reuters.com Newsletter

J&J says Indian drug regulators visited facilities, took talc samples

Indian drug authorities visited some of Johnson & Johnson's facilities on Wednesday and took "tests and samples" of its talcum powder, the company said in a statement.

China reports first African swine fever outbreak in Guangdong province

China confirmed on Wednesday the first African swine fever outbreak in southern Guangdong province, as the highly contagious disease continues to spread through the world's largest hog herd.

Drugmaker GSK to split after striking Pfizer consumer health deal

GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division.

J&J says Indian drug regulators visited facilities, company provided talc samples

Johnson & Johnson said on Wednesday that Indian drugs authorities visited some of its facilities and it provided them with "tests and samples" of its talcum powder.

Molecular Partners agrees cancer immunotherapy deal with Amgen

Swiss biotechnology company Molecular Partners said it could earn more than $500 million in payments after striking a deal with U.S. drug giant Amgen to work together in cancer immunotherapy.

Indian regulator to test samples of Johnson & Johnson baby powder: media

India's federal drug regulator will on Wednesday seize samples of Johnson & Johnson's baby powder for testing, local media said, following a Reuters report that the company knew for decades that cancer-causing asbestos lurked in the product.

Allergan stops sales in Europe of breast implants linked to cancer

Breast implants made by drugmaker Allergan, which have been linked to a rare form of cancer, are being taken off the market in Europe, said a French regulatory body.

Pharma industry returns on R&D investment hit nine-year low

The cost of developing a new drug has nearly doubled since 2010 and the world's 12 biggest drugmakers are making the lowest return on their R&D investments in nine years, according to Deloitte.

More U.S. adults may be trying to lose weight, after all

(Reuters Health) - - Researchers said last year that the proportion of overweight U.S. adults trying to lose weight has been shrinking - but newly reanalyzed data suggest the proportion of adults trying to slim down actually grew slightly.

J&J moves to limit impact of Reuters report on asbestos in Baby Powder

Johnson & Johnson on Monday scrambled to contain fallout from a Reuters report that the healthcare conglomerate knew for decades that cancer-causing asbestos lurked in its Baby Powder, taking out full-page newspaper ads defending its product and practices, and readying its chief executive for his first television interview since investors erased tens of billions of dollars from the company's market value.

FDA panel backs prescribing opioid overdose reversal drug along with painkillers

An advisory panel to the U.S. Food and Drug Administration on Tuesday recommended prescribing the opioid overdose reversal drug, naloxone, along with addictive painkillers.

Related Videos

Grammy nominations focus on diversity

Kevin Hart quits as Oscar host over old tweets

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS